ALKBH5 and neoplasm: In pancreatic cancer, ALKBH5 relies on the demethylation of Wnt inhibitory factor 1 (WIF-1) and the activation of Wnt signal to inhibit tumorigenesis and make tumor cells more sensitive to chemotherapy (105).